DISOPYRAMIDE KINETICS IN RENAL IMPAIRMENT - DETERMINANTS OF INTERINDIVIDUAL VARIABILITY

被引：15

作者：

BURK, M ^{[1
]}

PETERS, U ^{[1
]}

机构：

[1] UNIV DUSSELDORF,MED KLIN A,D-4000 DUSSELDORF,FED REP GER

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 34卷 / 03期

关键词：

D O I：

10.1038/clpt.1983.176

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：331 / 340

页数：10

共 24 条

[1]

AITIO ML, 1982, INT J CLIN PHARM TH, V20, P219

[2] PLASMA-CONCENTRATIONS AND PROTEIN-BINDING OF DISOPYRAMIDE AND MONO-N-DEALKYLDISOPYRAMIDE DURING CHRONIC ORAL DISOPYRAMIDE THERAPY [J].

AITIO, ML .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (04) :369-375

[3] CONGRUENCE OF CREATININE AND INULIN CLEARANCES IN CHILDREN - USE OF TECHNICON AUTOANALYZER [J].

ARANT, BS ;

SPITZER, A ;

EDELMANN, CM .

JOURNAL OF PEDIATRICS, 1972, 81 (03) :559-+

[4]

BERLYNE GM, 1964, LANCET, V2, P874

[5] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[6] DISOPYRAMIDE SERUM AND PHARMACOLOGIC EFFECT KINETICS APPLIED TO ASSESSMENT OF BIOAVAILABILITY [J].

BRYSON, SM ;

WHITING, B ;

LAWRENCE, JR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) :409-419

[7] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[8]

DIXON WJ, 1979, BMDP79 BIOMEDICAL CO

[9]

DUDUBOIS, 1916, ARCH INTERN MED, V17, P863

[10] THE EFFECT OF SATURABLE BINDING TO PLASMA-PROTEINS ON THE PHARMACOKINETIC PROPERTIES OF DISOPYRAMIDE [J].

GIACOMINI, KM ;

SWEZEY, SE ;

TURNERTAMIYASU, K ;

BLASCHKE, TF .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (01) :1-14

← 1 2 3 →